CHU de Liège - Domaine universitaire du Sart Tilman

Liège 4000

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Clostridium Difficile Infection, Gastric Cancer, Gastroesophageal Junction Cancer, Hematological Malignancies, Receptors, Fibroblast Growth Factor, Urothelial Cancer, Urothelial Carcinoma

Studies at this site

• A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer — Running, not enrolling
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed